## Abstract ## Objective: To determine progression and prognostic factors of progression rate of motor impairment, disability, and quality of life (QoL) in patients with newly diagnosed Parkinson's disease. ## Methods: A group of 126 patients with newly diagnosed PD recruited from outpatient cli
Distribution of motor impairment influences quality of life in Parkinson's disease
β Scribed by Kim C. Stewart; Hubert H. Fernandez; Michael S. Okun; Charles E. Jacobson; Chris J. Hass
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 418 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
We evaluated the relationship between upper extremity (UE) and lower extremity (LE) motor impairments in Parkinson's disease (PD) to overall disability and quality of life (QoL) measures. A total of 639 patients who were diagnosed with idiopathic PD were administered the Unified Parkinson's Disease Rating Scale (UPDRS), QoL, activities of daily living (ADL), and behavioral scales. Composite UE and LE scores from the motor section of the UPDRS were correlated with ADL, QoL, and behavioral measurement scores while controlling for disease duration. Patients with greater UE and LE motor impairments had lower QoL scores. However, LE impairments had a greater influence than UE impairments across all QoL measures. Β© 2008 Movement Disorder Society
π SIMILAR VOLUMES
The objective of this study was to examine the quality of life in patients with Parkinson's disease (PD) in a community-based sample (n β«Χ‘β¬ 228 patients) using a Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) as a measure. Associations to the variables age, age at onset, duration, c
## Abstract The impact of dyskinesias and motor fluctuations on quality of life (QOL) at various stages in the course of Parkinson's disease (PD) is not well understood. In 301 subjects with early PD enrolled in a clinical trial (CALMβPD), we quantified the impact of motor complications on QOL and
OBJECTIVE: To monitor comparative progression of clinical impairment over 4 years in patients with Parkinson's disease (PD) who present on levodopa at two different levels of Hoehn and Yahr (HY) stages, II and III. BACKGROUND: The rate of clinical impairment progression in patients with PD being tr
## Abstract The impact of motor complications of Parkinson's disease (PD), especially levodopaβinduced dyskinesias, on quality of life (QL) was studied in 143 patients with PD. All were evaluated on the Hoehn and Yahr (H&Y) scale, and the Motor part of the Unified Parkinson's Disease Rating Scale (